Where Sangrix stands after its latest Filing
Sangrix has little or no product revenue yet; it used $3m of cash in the twelve months. The diluted share count is down 99.6% on a year earlier, which lifts each remaining share.
Our model value for Sangrix is under review, so past values are not shown until it is resolved.